Patients with chronic lymphocytic leukaemia (CLL) are divided into high-, medium-, and low-risk groups based on their symptoms and risk levels. The presence or absence of less-favorable genetic abnormalities, such as del(17p), del(11q), TP53 malfunction, and IGHV mutations, affects the prognosis for CLL, as these markers are linked to poor treatment response.
- Chronic lymphocytic leukaemia is a malignancy in which the bone marrow produces an excessive number of lymphocytes (a type of white blood cell).
- Red blood cells, white blood cells, and platelets can all be affected by leukaemia.
- Swollen lymph nodes and fatigue are signs and symptoms of chronic lymphocytic leukaemia.
- The diagnosis of chronic lymphocytic leukaemia is made through blood tests.
- Treatment options and prognosis are influenced by a number of factors (chance of recovery).
To Know More: https://bit.ly/3v7Nfd0